Literature DB >> 33670616

Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling.

Elvira Immacolata Parrotta1, Anna Procopio2, Stefania Scalise2, Claudia Esposito2, Giovanni Nicoletta2, Gianluca Santamaria2,3, Maria Teresa De Angelis2,3, Tatjana Dorn3, Alessandra Moretti3,4, Karl-Ludwig Laugwitz3,4, Francesco Montefusco5, Carlo Cosentino2, Giovanni Cuda2.   

Abstract

Arrhythmogenic Right Ventricular cardiomyopathy (ARVC) is an inherited cardiac muscle disease linked to genetic deficiency in components of the desmosomes. The disease is characterized by progressive fibro-fatty replacement of the right ventricle, which acts as a substrate for arrhythmias and sudden cardiac death. The molecular mechanisms underpinning ARVC are largely unknown. Here we propose a mathematical model for investigating the molecular dynamics underlying heart remodeling and the loss of cardiac myocytes identity during ARVC. Our methodology is based on three computational models: firstly, in the context of the Wnt pathway, we examined two different competition mechanisms between β-catenin and Plakoglobin (PG) and their role in the expression of adipogenic program. Secondly, we investigated the role of RhoA-ROCK pathway in ARVC pathogenesis, and thirdly we analyzed the interplay between Wnt and RhoA-ROCK pathways in the context of the ARVC phenotype. We conclude with the following remark: both Wnt/β-catenin and RhoA-ROCK pathways must be inactive for a significant increase of PPARγ expression, suggesting that a crosstalk mechanism might be responsible for mediating ARVC pathogenesis.

Entities:  

Keywords:  RhoA-ROCK pathway; Wnt/β-catenin signaling; adipogenesis; arrhythmogenic right ventricular cardiomyopathy (ARVC); induced pluripotent stem cells (iPSCs); mathematical model; system biology

Mesh:

Substances:

Year:  2021        PMID: 33670616      PMCID: PMC7923182          DOI: 10.3390/ijms22042004

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  44 in total

Review 1.  Wnt/beta-catenin signaling: components, mechanisms, and diseases.

Authors:  Bryan T MacDonald; Keiko Tamai; Xi He
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

Review 2.  Validation and invalidation of systems biology models using robustness analysis.

Authors:  D G Bates; C Cosentino
Journal:  IET Syst Biol       Date:  2011-07       Impact factor: 1.615

3.  Regulation of MKL1 via actin cytoskeleton dynamics drives adipocyte differentiation.

Authors:  Hiroyuki Nobusue; Nobuyuki Onishi; Takatsune Shimizu; Eiji Sugihara; Yoshinao Oki; Yuko Sumikawa; Tatsuyuki Chiyoda; Koichi Akashi; Hideyuki Saya; Koichiro Kano
Journal:  Nat Commun       Date:  2014-02-26       Impact factor: 14.919

Review 4.  Recent advances in mathematical modeling and statistical analysis of exocytosis in endocrine cells.

Authors:  Morten Gram Pedersen; Alessia Tagliavini; Giuliana Cortese; Michela Riz; Francesco Montefusco
Journal:  Math Biosci       Date:  2016-11-09       Impact factor: 2.144

5.  Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Raffaella Lombardi; Maria da Graca Cabreira-Hansen; Achim Bell; Richard R Fromm; James T Willerson; A J Marian
Journal:  Circ Res       Date:  2011-10-20       Impact factor: 17.367

6.  A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways.

Authors:  D Kim; O Rath; W Kolch; K-H Cho
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

Review 7.  Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians.

Authors:  Frank I Marcus; Sue Edson; Jeffrey A Towbin
Journal:  J Am Coll Cardiol       Date:  2013-03-14       Impact factor: 24.094

8.  Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity.

Authors:  Tatjana Dorn; Jessica Kornherr; Elvira I Parrotta; Dorota Zawada; Harold Ayetey; Gianluca Santamaria; Laura Iop; Elisa Mastantuono; Daniel Sinnecker; Alexander Goedel; Ralf J Dirschinger; Ilaria My; Svenja Laue; Tarik Bozoglu; Christian Baarlink; Tilman Ziegler; Elisabeth Graf; Rabea Hinkel; Giovanni Cuda; Stefan Kääb; Andrew A Grace; Robert Grosse; Christian Kupatt; Thomas Meitinger; Austin G Smith; Karl-Ludwig Laugwitz; Alessandra Moretti
Journal:  EMBO J       Date:  2018-05-15       Impact factor: 11.598

9.  Comprehensive proteogenomic analysis of human embryonic and induced pluripotent stem cells.

Authors:  Elvira Immacolata Parrotta; Stefania Scalise; Domenico Taverna; Maria Teresa De Angelis; Gianmarco Sarro; Marco Gaspari; Gianluca Santamaria; Giovanni Cuda
Journal:  J Cell Mol Med       Date:  2019-06-25       Impact factor: 5.310

Review 10.  Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.

Authors:  Elvira Immacolata Parrotta; Stefania Scalise; Luana Scaramuzzino; Giovanni Cuda
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

View more
  4 in total

Review 1.  Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells.

Authors:  Tarek Khedro; Jason M Duran; Eric D Adler
Journal:  Curr Cardiol Rep       Date:  2022-06-03       Impact factor: 3.955

Review 2.  Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications.

Authors:  Ioannis Akoumianakis; Murray Polkinghorne; Charalambos Antoniades
Journal:  Nat Rev Cardiol       Date:  2022-06-13       Impact factor: 49.421

Review 3.  Recent Fabrication Methods to Produce Polymer-Based Drug Delivery Matrices (Experimental and In Silico Approaches).

Authors:  Anna Procopio; Elena Lagreca; Rezvan Jamaledin; Sara La Manna; Brunella Corrado; Concetta Di Natale; Valentina Onesto
Journal:  Pharmaceutics       Date:  2022-04-15       Impact factor: 6.525

Review 4.  Insight Into Rho Kinase Isoforms in Obesity and Energy Homeostasis.

Authors:  Lei Wei; Jianjian Shi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-13       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.